Filing Analysis
Other SEC Filing
Filed May 07, 2026
LOW
IN8bio, Inc. reported its Q1 2026 financial results and announced the results of its 2026 Annual Meeting of Stockholders. Shareholders approved an Amended and Restated 2026 Equity Incentive Plan, which increases the share pool and extends the plan's duration.
Red Flags
- Potential shareholder dilution resulting from the 2,920,000 share increase in the equity incentive plan and the extension of the evergreen provision through 2037.
Key Facts
- Announced Q1 2026 financial results for the period ended March 31, 2026.
- Stockholders approved the Amended and Restated 2026 Equity Incentive Plan, increasing the share pool by 2,920,000 shares.
- The 2026 Plan extends the annual share increase ('evergreen') provision through 2037.
- Established a maximum of 20,000,000 shares for issuance as Incentive Stock Options (ISOs).
- Peter Brandt and Corinne Epperly were elected as Class II directors to serve until 2029.
- CohnReznick LLP was ratified as the independent registered public accounting firm for the fiscal year ending December 31, 2026.
Regulation FD Disclosure
Filed Mar 12, 2026
LOW
IN8bio, Inc. announced its financial results for the fourth quarter and fiscal year ended December 31, 2025, via a press release on March 12, 2026.
Key Facts
- The filing reports financial results for the fiscal year ended December 31, 2025.
- The information was furnished under Item 2.02 Results of Operations and Financial Condition.
- The report was signed by Patrick McCall, Chief Financial Officer and Secretary.
- A press release dated March 12, 2026, was included as Exhibit 99.1.
Officer Departure
Filed Feb 27, 2026
MEDIUM
Alan S. Roemer resigned from the Board of Directors and its Audit and Compensation Committees effective February 28, 2026. The company has appointed independent director Jeremy Graff as Interim Chair of the Board to fill the vacancy.
Red Flags
- Resignation from the Audit Committee, which requires oversight of financial reporting.
- Appointment of an 'Interim' Chair suggests an unplanned transition or lack of a permanent succession plan.
Key Facts
- Alan S. Roemer notified the Board of his resignation on February 26, 2026.
- The resignation is effective as of February 28, 2026.
- Mr. Roemer was a member of both the Audit and Compensation Committees.
- Jeremy Graff, an independent director, was appointed as Interim Chair of the Board.
- The filing states the resignation was not the result of any disagreement with the Company.
Disclaimer: This analysis is generated by AI and is for informational purposes only.
It does not constitute financial advice, investment recommendations, or an offer to buy or sell securities.
Always review the original SEC filings and consult a financial advisor before making investment decisions.